Form 8-K - Current report:
SEC Accession No. 0001753926-25-000722
Filing Date
2025-05-01
Accepted
2025-05-01 17:05:54
Documents
14
Period of Report
2025-05-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084795_8k.htm   iXBRL 8-K 25999
2 EXHIBIT 99.1 g084795_ex99-1.htm EX-99.1 4250
  Complete submission text file 0001753926-25-000722.txt   207504

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE chro-20250501.xsd EX-101.SCH 3029
4 XBRL LABEL FILE chro-20250501_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE chro-20250501_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT g084795_8k_htm.xml XML 3812
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Channel Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 25904249
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)